Suchergebnisse - "9NDF7JZ4M3"

PubPharm (623)

1

Comparison of High- and Low-Dose Rivaroxaban Regimens in Elderly East Asian Patients With Atrial Fibrillation

enthalten in: Journal of Korean medical science | 2024

von Kim, J. | Kim, J. | Park, S. | +9

2

Comparative analysis of andexanet alfa and prothrombin complex concentrate in reversing anticoagulation by rivaroxaban ex vivo

enthalten in: British journal of anaesthesia | 2024

von Rayatdoost, F. | Deventer, K. | Rossaint, R. | +2

3

Comparison of the effectiveness and safety of direct oral anticoagulants : a nationwide propensity score-weighted study

enthalten in: Blood advances | 2023

von Ingason, A. | Hreinsson, J. | Agustsson, A. | +7

4

Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants : Insight from the AFTER-2 trial

enthalten in: Kardiologia polska | 2023

von Aktan, A. | Güzel, T. | Aslan, B. | +6

CommentIn: Kardiol Pol. 2023;81(2):105-106. - PMID 36866399

5

Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population : updated analysis

enthalten in: Current medical research and opinion | 2022

von Amin, A. | Keshishian, A. | Hines, D. | +6

6

Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels

enthalten in: The Annals of pharmacotherapy | 2022

von Dingus, S. | Smith, A. | Dager, W. | +3

7

Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation

enthalten in: The New England journal of medicine | 2022

von Connolly, S. | Karthikeyan, G. | Ntsekhe, M. | +135

CommentIn: N Engl J Med. 2022 Sep 15;387(11):1036-1038. - PMID 36036520

8

Expression of anti and pro-inflammatory genes in human endothelial cells activated by 25-hydroxycholesterol : A comparison of rivaroxaban and dabigatran

enthalten in: Clinical and experimental pharmacology & physiology | 2022

von Gorzelak-Pabiś, P. | Pawlos, A. | Broncel, M. | +2

9

A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation : effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

enthalten in: Expert opinion on pharmacotherapy | 2022

von Esteve-Pastor, M. | Rivera-Caravaca, J. | Ruiz-Ortiz, M. | +11

10

Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism

enthalten in: JAMA | 2022

von Pawar, A. | Gagne, J. | Gopalakrishnan, C. | +5

CommentIn: JAMA. 2022 Jul 5;328(1):78-79. - PMID 35788799

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[63]